Axel Tosikyan

Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas

Ryan D. Morin, Sarit Assouline, Miguel Alcaide et al. · Clinical Cancer Research · 2015 · 227 citations

Life Sciences, Genetics, Molecular Genetics +14

Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma

Sarit Assouline, Torsten Holm Nielsen, Stephen Yu et al. · Blood · 2016 · 140 citations · Full text

Medicine, Hematology, Oncology +9

Treatment of Metastatic Spinal Cord Compression: cepo Review and Clinical Recommendations

Sylvain L’Espérance, F. Vincent, Mathieu Gaudreault et al. · Current Oncology · 2012 · 56 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Impact of renal impairment on outcomes with lenalidomide and dexamethasone treatment in the FIRST trial, a randomized, open-label phase 3 trial in transplant-ineligible patients with multiple myeloma

Meletios Α. Dimopoulos, Matthew C. Cheung, Murielle Roussel et al. · Haematologica · 2015 · 40 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +16

Isatuximab in combination with cemiplimab in patients with relapsed/refractory multiple myeloma: A phase 1/2 study

Alexander M. Lesokhin, Richard LeBlanc, Meletios Α. Dimopoulos et al. · Cancer Medicine · 2023 · 15 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15